File Browser

ALLERGAN INC. v. PHARMASCIENCE INC. ET AL.

Summary of T-524-20

The following information was obtained from the Federal Court or Federal Court of Appeal websites but is NOT the official version. See links below for the court websites.

Federal Court Type: Patented Medicines (NOC) Regulations [Actions]

Parties and Lawyers:
PartyFirmLawyer
ALLERGAN INCMCCARTHY TETRAULT LLPTANNER, STEVEN
KISSEI PHARMACEUTICAL CO LTD
PHARMASCIENCE INC
Intellectual Property:
NameNumber
2496780
RAPAFLO
2507002

Patented Medicine: Silodosin (Medicinal ingredients are based on automated analysis and should not be relied upon.)

Docket Summary (Google Translate to English)

(10) 2021-04-26 - Toronto
Consent on behalf of all parties to doc. 9 filed on 26-APR-2021
(9) 2021-04-26 - Toronto
Discontinuance on behalf of Plaintiff filed on 26-APR-2021
() 2021-04-09 - Ottawa
Toronto 09-APR-2021 BEFORE Martha Milczynski, Prothonotary Language: E Before the Court: Case Management Conference Result of Hearing: parties to provide further update by 23-APR-2021 held by way of Conference Call in chambers Duration per day: 09-APR-2021 from 10:00 to 10:04 Courtroom : Judge's Chambers - Toronto Court Registrar: Jake Schutz Total Duration: 4min Appearances: Mr. Mendis n/a representing Plaintiff Ms. Ramamoorthy n/a representing Defendant Minutes of Hearing entered in Vol. 1062 page(s) 90 - 90 Abstract of Hearing placed on file
() 2020-12-02 - Toronto
Letter from Defendant dated 02-DEC-2020 requesting a CMC received on 02-DEC-2020
() 2020-12-03 - Toronto
Acknowledgment of Receipt received from all parties with respect to doc. 8 received by email placed on file on 03-DEC-2020
(8) 2020-12-03 - Ottawa
Order dated 03-DEC-2020 rendered by C. Perrier, Judicial Administrator Matter considered without personal appearance The Court's decision is with regard to Trial of the matter Result: will take olace before tus Court at 180 Queen Street West, in the City of Toronto, Ontario, on Monday, the 7th of February, 2022, at 9:30 in the forenoon for a duration of ten (10) days Filed on 03-DEC-2020 certified copies sent to parties entered in J. & O. Book, volume 1472 page(s) 246 - 246 Interlocutory Decision
() 2020-08-13 - Toronto
Acceptance of Service received from all parties with respect to doc. 7 received by email placed on file on 13-AUG-2020
(7) 2020-08-13 - Toronto
Protective Order dated 13-AUG-2020 rendered by Martha Milczynski, Prothonotary Matter considered without personal appearance The Court's decision is with regard to Letter from Plaintiff dated 24-JUL-2020 re: Protective Order Result: granted Filed on 13-AUG-2020 certified copies sent to parties entered in J. & O. Book, volume 1465 page(s) 80 - 93 Interlocutory Decision
(6) 2020-06-15 - Toronto
Solicitor's certificate of service on behalf of Sanjaya Mendis confirming service of doc. 5 upon Defendant by email on 15-JUN-2020 filed on 15-JUN-2020
(5) 2020-06-15 - Toronto
Reply to Defence on behalf of Plaintiff Filed on 15-JUN-2020
(4) 2020-06-05 - Toronto
Solicitor's certificate of service on behalf of Frederick Wu confirming service of doc. 3 upon Plaintiff by email on 05-JUN-2020 filed on 05-JUN-2020
(3) 2020-06-05 - Toronto
Defence filed on 05-JUN-2020
() 2020-05-27 - Toronto
Letter from Plaintiff dated 26-MAY-2020 This letter contains a status update and a schedule from the parties received on 27-MAY-2020
() 2020-05-15 - Toronto
Oral directions received from the Court: Martha Milczynski, Prothonotary dated 15-MAY-2020 directing that "Request to validate service per correspondence dated May 15th 2020 granted. placed on file on 15-MAY-2020
() 2020-05-15 - Toronto
Letter from Plaintiff dated 15-MAY-2020 This letter requests that the attached email constitute email service of doc 1, and asks to be placed before Prothonotary Milczynski received on 15-MAY-2020
() 2020-05-06 - Ottawa
Acknowledgment of Receipt received from counsel via email with respect to doc#2 placed on file on 06-MAY-2020
(2) 2020-05-05 - Ottawa
Order dated 05-MAY-2020 rendered by Chief Justice Crampton Matter considered without personal appearance The Court's decision is with regard to Letter from Plaintiff dated 05-MAY-2020 re: request that this action be specially managed Result: "IT IS ORDERED pursuant to Rule 383 that Prothonotary Martha Milczynski is assigned as Case Management Judge in this matter." Filed on 05-MAY-2020 copies sent to counsel via email entered in J. & O. Book, volume 1452 page(s) 294 - 294 Interlocutory Decision
() 2020-05-05 - Toronto
Oral directions received from the Court: Martha Milczynski, Prothonotary dated 05-MAY-2020 directing that The Plaintiffs shall provide a copy of this direction to the defendant upon being served with the notice of intention to respond. The parties shall within 7 days thereafter, consult with one another and submit: 1)An update as to the status of the proceeding, indicating their mutual availability, number of days required (not exceeding 10 days) and the preferred venue for the trial in this action; 2)A jointly proposed timetable for the steps leading up to the trial in this action, having regard to the steps identified in the attached checklist as applicable; 3)Dates and times of mutual availability for a case management teleconference Also, when filing pleadings with the court, please ensure a courtesy copy is sent to the case management team in Toronto cmt_toronto@cas-satj.gc.ca placed on file on 05-MAY-2020
() 2020-05-04 - Toronto
Letter from Plaintiff dated 04-MAY-2020 requesting that this action be specially managed pursuant to Rules 383, 383.1 and 385 of Federal Court Rules; there is currently another proceeding before the court involving same drug, being specially managed by Prothonotary Milczynski; Allergan does not renounce the stay under paragragh 7(5)(b) of the Regulations in respect of this action. received on 04-MAY-2020
(1) 2020-05-04 - Toronto
Statement of Claim filed on 04-MAY-2020 Tariff other action - $150.00

The official version of the court proceeding information is available from the court websites directly:
Browse another proceeding. Enter Court File No:

Canadian Intellectual Property